Retinol in Canada: Cosmetic Ingredient or Regulated Active

Retinol shows up in a lot of Canadian formulas right now, and the question that trips people up isn't whether they can use it. It's whether the product is still a cosmetic once retinol is in it and the label says what the maker wants it to say.

The ingredient itself

Retinol's INCI name is simply Retinol, and its CAS number is 68-26-8. It sits on the Cosmetic Ingredient Hotlist, which is Health Canada's living list of substances that are prohibited or restricted in cosmetics sold in Canada. Being on the Hotlist doesn't mean retinol is banned. It means there's a condition attached, typically a concentration limit, and you need to check the current Hotlist entry before you file, because these entries get revised.

When you file your Cosmetic Notification Form (CNF), retinol goes in under its INCI name with the concentration or concentration range you're actually using. If your formula uses a supplier blend, a retinol-in-oil dilution for example, you need to work out retinol's real percentage in the finished product, not just the blend's use level. A blend that's 10% retinol used at 2% of the formula puts actual retinol at 0.2%, and that's the number that matters against the Hotlist limit.

Where it tips into drug territory

This is the part that actually decides your regulatory path. Retinol used as a cosmetic ingredient, something that helps skin feel smoother or look more radiant, can be notified as a cosmetic. But the moment your claims cross into treating a condition (acne, wrinkles as a medical concern, cellular renewal framed as a drug-like effect), you've moved into territory Health Canada treats differently.

The distinction Health Canada draws is about the claim, not the molecule. A short list of the kind of language that keeps you on the cosmetic side versus pulls you toward drug status:

• Cosmetic-leaning claims: smooths the look of skin, helps skin appear more even, supports a youthful appearance, hydrates and softens
• Drug-leaning claims: reduces wrinkles (framed as treatment), treats acne, repairs skin damage, reverses aging at a cellular level

Retinoic acid and higher-strength prescription retinoids are a different story entirely and are handled as drugs, not cosmetics. Retinol itself, at cosmetic concentrations with cosmetic claims, is the ingredient makers can usually notify. But "usually" is doing real work in that sentence, because claim wording varies by brand and marketing team, and a claims review is worth doing before you finalize copy, not after you've printed labels.

What goes on the CNF and the label

Once you've settled the claim question, the mechanics are the same as any other ingredient:

Item	What's needed
INCI name	Retinol
CAS number	68-26-8
Concentration	Actual percentage or range in finished product
Hotlist check	Confirm current restriction, if any, before filing
Filing window	Within 10 days of first sale
Label language	Bilingual, English and French

If retinol is one ingredient among several new actives (niacinamide, peptides, AHAs), each one gets the same treatment: INCI name, real concentration, Hotlist check. It's common for a "simple" retinol serum to actually be five or six ingredients that each need this same scrutiny, and the Hotlist doesn't only flag retinol, it flags whatever else is riding along in the formula.

Fragrance allergens if retinol shares a formula with scent

If your retinol product is fragranced, remember the separate allergen disclosure timeline. List 1 fragrance allergens become mandatory on the CNF and label on April 12, 2026, and List 2, the expanded set aligned with international lists, becomes mandatory August 1, 2026. Disclosure triggers above 0.001% (10 ppm) in leave-on products, which most retinol serums and creams are. That's a separate compliance track from the retinol question itself, but it lands on the same label, so plan for both at once.

A practical way to check yourself before filing

Before you notify, walk through three questions:

1. What is retinol's actual concentration in the finished product, after accounting for any supplier blend dilution?
2. Does the current Hotlist entry for retinol allow that concentration, or does it cap lower?
3. Does every claim on the label and in marketing copy stay on the cosmetic side of the line, or does any phrase suggest treating a condition?

If any answer is unclear, that's the point to slow down rather than file and hope. Cosmetic Comply's screening step is built for exactly this kind of ingredient, it maps retinol to its INCI and CAS, carries the real concentration through from any blend, checks it against the current Hotlist, and flags a confidence score before a human reviewer signs off and the filing goes in. For a maker juggling several new actives in one launch, that's a lot less guesswork than doing it ingredient by ingredient by hand.